OOIR: Observatory of International Research

Papers

(The H4-Index of Hepatology Communications is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)

Article	Citations
Hsa_circ_0109623 regulates the progression of autoimmune liver disease through Hsa_miR_146b-3p/Sortilin 1–mediated activation of CD4+ T cells	167
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement	127
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores	118
Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda	85
Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD	76
Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival	74
Disproportionate increases in alcohol-associated hepatitis incidence in women and individuals of low socioeconomic status: A population-based study using the Rochester epidemiology project database	69
Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump	65
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH	57
Assessing the risk of surgery in patients with cirrhosis	50
Presence of pseudo-Kayser-Fleischer rings in patients without Wilson disease: a prospective cohort study	50
	50
Poor emotional well-being and energy are associated with mortality in patients with advanced liver failure	48
	46
	46
	46
	43
Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol-Associated Liver Disease	43
In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing Technology	43
Mitochondrial quality control in alcohol-associated liver disease	43
Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care	41
Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma	41
Optimal alpha-1 antitrypsin level cutoffs for genotype identification in patients with chronic liver disease	40
An Experimental DUAL Model of Advanced Liver Damage	40
Malassezia restricta promotes alcohol-induced liver injury	39

Meta‐analysis and Consolidation of Farnesoid X Receptor Chromatin Immunoprecipitation Sequencing Data Across Different Species and Conditions	38
Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition	37
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis	36
Mandatory Hepatology Education for Internal Medicine Residents: Long‐Term Effects and Implications for Workforce Needs	36
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH	35
Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis	34
Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal	34
Wilson disease: a summary of the updated AASLD Practice Guidance	33
Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR	33
Reduced short-term survival following liver transplant in patients with acute-on-chronic liver failure: Reevaluating OPTN data	33